Exchange: NASDAQ·Updated 09:44 AM EDT

SCTX Scribe Therapeutics

$19.50
$1.17
(5.66%)
Today
EarningsNov 11
Mkt Cap$391.32M
Vol1,316.00

About SCTX

Scribe Therapeutics, Inc. is a clinical-stage biotechnology company. It is engaged in the development of in vivo therapies. It develops custom engineered enzymes and delivery modalities as part of a proprietary, evergreen platform for CRISPR-based genetic medicine. The company was founded in June 2017 by Jennifer A. Doudna, Benjamin L. Oakes, David F. Savage, and Brett T. Staahl and is headquartered in Alameda, CA.
39

Bearish Sentiment

How do you feel about SCTX?

Advertisement|Remove ads.